Rhythm Pharmaceuticals, Inc.
NASDAQRhythm Pharmaceuticals enters the back half of the week trading 10% higher, powered by a strong Q1 earnings beat that sent analysts scrambling to revise their models upward — while shorts hold their ground at the highest level in months. The week's defining move was Tuesday's 7.9% surge to $92.31, itself the continuation of a broader 10% gain across the past five sessions. Q1…
Snapshot as of 7 May 2026
Rhythm Pharmaceuticals enters the back half of the week trading 10% higher, powered by a strong Q1 earnings beat that sent analysts scrambling to revise their models upward — while shorts hold their ground at the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RYTM — free to start on ORTEX.
Sign up for free →Open RYTM on ORTEX